Novartis Finalizes $390-Million Settlement

Novartis Finalizes $390-Million Settlement

Earlier this year, the Justice Department filed a lawsuit seeking as much as $3.35 billion in damages in fines from Novartis over allegations that the drugmaker created kickback schemes to increase sales of the iron chelation therapy Exjade (deferasirox) and the kidney transplant drug Myfortic (myco...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical Processing 2015-11
1. Verfasser: Barber, Joe
Format: Artikel
Sprache:eng
Schlagworte:
Drug stores
Pharmaceutical industry
Pharmacy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Earlier this year, the Justice Department filed a lawsuit seeking as much as $3.35 billion in damages in fines from Novartis over allegations that the drugmaker created kickback schemes to increase sales of the iron chelation therapy Exjade (deferasirox) and the kidney transplant drug Myfortic (mycophenolic acid).
ISSN:1049-9156